Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi)

Oncogene

Volumn 21, Issue 37, 2002, Pages 5716-5724

  Wilda, Monika ^a   Fuchs, Uta ^a   Wössmann, Wilhelm ^a   Borkhardt, Arndt ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Apoptosis; BCR ABL rearrangement; Gene therapy; RNA interference; STI 571

Indexed keywords

BCR ABL PROTEIN; DOUBLE STRANDED RNA; IMATINIB; ONCOPROTEIN;

APOPTOSIS; ARTICLE; CELL KILLING; CONTROLLED STUDY; FUSION GENE; GENE SILENCING; HUMAN; HUMAN CELL; LEUKEMIA CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

APOPTOSIS; GENE SILENCING; GENE THERAPY; GENES, ABL; HUMAN; K562 CELLS; LEUKEMIA; PIPERAZINES; PYRIMIDINES; RNA, DOUBLE-STRANDED; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T;

EID: 0037158901     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205653     Document Type: Article

References (37)

1. Barthe C, Cony-Makhoul P, Melo JV and Mahon JR. (2001). Science, 293, 2163.
2. Brummelkamp TR, Bernards R and Agami R. (2002). Science, 296, 550-553.
3. Carroll M, Ohno-Jones S, Tamura S, Buchdunger E, Zimmermann J, Lydon NB, Gilliland DG and Druker BJ. (1997). Blood, 90, 4947-4952.
4. Chan LC, Karhi KK, Rayter SJ, Heisterkamp N, Eridani S, Powles R, Lawler SD, Groffen J, Foulkes JG, Greaves MF and Wiedemann LM. (1987). Nature, 325, 635.
5. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie AN, King G and Rabbitts TH. (1996). Cell, 85, 853-861.
6. Daley GQ, van Etten RA and Baltimore D. (1990). Science, 247, 824-830.
7. Dhut S, Chaplin T and Young BD. (1990). Leukemia, 4, 745-750.
8. Dobrovic A, Morley AA, Seshadri R and Januszewicz EH. (1991). Leukemia, 5, 187-190.
9. Druker BJ, Sawyers CL, Capdeville R, Ford JM, Baccarani M and Goldman JM. (2001a). Hematology (Am. Soc. Hematol. Educ. Program.) 87-112.
10. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R and Talpaz M. (2001b). N. Engl. J. Med., 344, 1038-1042.
11. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S and Sawyers CL. (2001c). N. Engl. J. Med., 344, 1031-1037.
12. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J and Lydon NB. (1996). Nat. Med., 2, 561-566.
13. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. (2001a). Nature, 411, 494-498.
14. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W and Tuschl T. (2001b). EMBO J., 20, 6877-6888.
15. Goldman JM and Druker BJ. (2001a). Blood, 98, 2039-2042.
16. Goldman JM and Melo JV. (2001b). N. Engl. J. Med., 344, 1084-1086.
17. Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN and Sawyers CL. (2001). Science, 293, 876-880.
18. Hochhaus A, Kreil S, Corbin A, La Rosee P, Lahaye T, Berger U, Cross NC, Linkesch W, Druker BJ, Hehlmann R, Gambacorti-Passerini C, Corneo G and D'Incalci M. (2001). Science, 293, 2163.
19. Hooberman AL, Carrino JC, Leibowitz D, Rowley JD, Le Beau MM, Arlin Z and Westbrook CA. (1989). Proc. Natl. Acad. Sci. USA, 86, 4259.
20. Lestingi TM and Hooberman AL. (1993). Hematol. Oncol. Clin. North Am., 7, 161-175.
21. Lugo TG, Pendergast AM, Müller AJ and Witte ON. (1990). Science, 247, 1079-1082.
22. Mahon FX, Deininger MW, Schultheis B, Chabrol J, Reiffers J, Goldman JM and Melo JV. (2000). Blood, 96, 1070-1079.
23. Maurer J, Janssen JWG, Thiel E, Van Denderen J, Ludwig WD, Aydemir Ü, Heinze B, Fonatsch C, Harbott J, Reiter A, Riehm H, Hoelzer D and Bartram CR. (1991). Lancet, 337, 1055-1058.
24. McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR and Cotter TG. (1994). Blood, 83, 1179-1187.
25. Rabbitts TH. (1994). Nature, 372, 143-149.
26. Rabbitts TH. (1998). N. Engl. J. Med., 338, 192-194.
27. Ray S, Ponnathpur V, Huang Y, Tang C, Mahoney ME, Ibrado AM, Bullock G and Bhalla K. (1994). Cancer Chemother. Pharmacol., 34, 365-371.
28. Rowley JD. (1973). Nature, 243, 290-293.
29. Rowley JD. (1999). Semin. Hematol., 36, 59-72.
30. Rubin CM, Carrino JJ, Dickler MN, Leibowitz D, Smith SD and Westbrook CA. (1988). Proc. Natl. Acad. Sci. USA, 85, 2795-2799.
31. Scadden AD and Smith CW. (2001). EMBO Rep., 2, 1107-1111.
32. Skorski T, Nieborowska-Skorska M, Nicolaides NC, Szczylik C, Iversen P, Iozzo RV, Zon G and Calabretta B. (1994). Proc. Natl. Acad. Sci. USA, 91, 4504-4508.
33. Smetsers TF, Skorski T, van de Locht LT, Wessels HM, Pennings AH, de Witte T, Calabretta B and Mensink EJ. (1994). Leukemia, 8, 129-140.
34. Spiller DG, Giles RV, Grzybowski J, Tidd DM and Clark RE. (1998). Blood, 91, 4738-4746.
35. Stein CA and Narayanan R. (1994). Curr. Opin. Oncol., 6, 587-594.
36. Tuschl T. (2002). Nat. Biotechnol., 20, 446-448.
37. Westbrook CA, Hooberman AL, Spino C, Dodge RK, Larson RA, Davey F, Wurster-Hill DH, Sobol RE, Schiffer C and Bloomfield CD. (1992). Blood, 80, 2983-2990.